Divalproex sodium vs. Keppra: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Divalproex sodium and Keppra. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 213,454 people who take Divalproex sodium and Keppra, and is updated regularly.
What is Divalproex sodium?
Divalproex sodium has active ingredients of divalproex sodium. It is often used in epilepsy. eHealthMe is studying from 9,483 Divalproex sodium users. Check the latest studies of Divalproex sodium.
What is Keppra?
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.
213,454 people who take Divalproex sodium and Keppra are studied.
Drugs being compared in this study:
- Divalproex Sodium (divalproex sodium)
- Keppra (levetiracetam)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Divalproex Sodium:
- not at all: 4.83 %
- somewhat: 21.01 %
- moderate: 31.11 %
- high: 29.01 %
- very high: 14.04 %
Keppra:
- not at all: 4.5 %
- somewhat: 13.46 %
- moderate: 22.84 %
- high: 35.08 %
- very high: 24.11 %
Want to compare Divalproex sodium with Keppra?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Divalproex sodium (9,296 reports)
- Keppra (70,381 reports)
Browse all side effects of Divalproex sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on divalproex sodium and levetiracetam (the active ingredients of Divalproex sodium and Keppra, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Prednisone and Trasylol - now
- Could Marine Triglyceride cause Haemorrhage? - 2 seconds ago
- Mycophenolate Mofetil and Urine Protein for Women aged 50-59 - 3 seconds ago
- Mycophenolate Mofetil and Urine Albumin for Women aged 50-59 - 3 seconds ago
- Mycophenolate Mofetil and Proteinuria for Women aged 50-59 - 3 seconds ago
- Mycophenolate Mofetil and Albuminuria for Women aged 50-59 - 4 seconds ago
- Mycophenolate Mofetil and Albumin - Urine for Women aged 50-59 - 4 seconds ago
- Mycophenolate Mofetil and Protein - Urine for Women aged 50-59 - 4 seconds ago
- Joint Pain in Paxil, how severe and when it was recovered? - 18 seconds ago
- Profen vs. Fentanyl-75, side effect and effectiveness comparison - 28 seconds ago